Correlation Between Phathom Pharmaceuticals and Fondo De

Can any of the company-specific risk be diversified away by investing in both Phathom Pharmaceuticals and Fondo De at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Phathom Pharmaceuticals and Fondo De into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Phathom Pharmaceuticals and Fondo de Inversion, you can compare the effects of market volatilities on Phathom Pharmaceuticals and Fondo De and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Phathom Pharmaceuticals with a short position of Fondo De. Check out your portfolio center. Please also check ongoing floating volatility patterns of Phathom Pharmaceuticals and Fondo De.

Diversification Opportunities for Phathom Pharmaceuticals and Fondo De

-0.68

Correlation Coefficient

Phathom Pharmaceuticals  Fondo De

Excellent diversification

The 3 months correlation between Phathom and Fondo is -0.68. Overlapping area represents the amount of risk that can be diversified away by holding Phathom Pharmaceuticals and Fondo de Inversion in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Fondo de Inversion and Phathom Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Phathom Pharmaceuticals are associated (or correlated) with Fondo De. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Fondo de Inversion has no effect on the direction of Phathom Pharmaceuticals i.e., Phathom Pharmaceuticals and Fondo De go up and down completely randomly.

Pair Corralation between Phathom Pharmaceuticals and Fondo De

Given the investment horizon of 90 days Phathom Pharmaceuticals is expected to generate 5.37 times more return on investment than Fondo De. However, Phathom Pharmaceuticals is 5.37 times more volatile than Fondo de Inversion. It trades about 0.06 of its potential returns per unit of risk. Fondo de Inversion is currently generating about 0.0 per unit of risk. If you would invest  989.00  in Phathom Pharmaceuticals on July 10, 2024 and sell it today you would earn a total of  621.00  from holding Phathom Pharmaceuticals or generate 62.79% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	98.38%
Values	Daily Returns

Phathom Pharmaceuticals  vs.  Fondo de Inversion

Phathom Pharmaceuticals

Risk-Adjusted Performance

14 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Phathom Pharmaceuticals are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Phathom Pharmaceuticals unveiled solid returns over the last few months and may actually be approaching a breakup point.

Fondo de Inversion

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Fondo de Inversion has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Fondo De is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.

Pair Trading with Phathom Pharmaceuticals and Fondo De

The main advantage of trading using opposite Phathom Pharmaceuticals and Fondo De positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Phathom Pharmaceuticals position performs unexpectedly, Fondo De can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fondo De will offset losses from the drop in Fondo De's long position.

The idea behind Phathom Pharmaceuticals and Fondo de Inversion pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.